Novel interferon-based antimyeloma activity
- PMID: 40014322
- DOI: 10.1182/blood.2024027417
Novel interferon-based antimyeloma activity
Comment on
-
Targeted interferon therapy with modakafusp alfa for relapsed or refractory multiple myeloma.Blood. 2025 Feb 27;145(9):944-955. doi: 10.1182/blood.2024026124. Blood. 2025. PMID: 39630057 Free PMC article. Clinical Trial.